ClinicalTrials HQ

OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients: a Randomized Factorial Controlled Strategy Trial

OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients: a Randomized Factorial Controlled Strategy Trial

Recruiting · NCT05587894 · Registry updated 2026-02-23
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients: a Randomized Factorial Controlled Strategy TrialCOVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, immune system disorder, immunodeficiency disease, inborn error of immunity, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumoniaRecruitingPhase 22026-02-23NCT05587894

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
ANRS, Emerging Infectious Diseases47

18 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Bichat Claude-Bernard HospitalParisFrance1
Croix Rousse HospitalLyonFrance1
Division of Infectious Diseases, Verona University HospitalVeronaItaly1
Drammen Hospital, Vestre Viken HospitalDrammenNorway1
Francois Mitterrand HospitalDijonFrance1
Hotel Dieu HospitalNantesFrance1
La Colombière HospitalMontpellierFrance1
Laribosière HospitalParisFrance1
Oslo University Hospital and University of OsloOsloNorway1
Pellegrin HospitalBordeauxFrance1
Pitié-Salpêtrière HospitalParisFrance2
Purpan HospitalToulouseFrance1
Robert Debré HospitalReimsFrance1
Saint Antoine HospitalParisFrance1
Saint Louis HospitalParisFrance1
Saint-André HospitalBordeauxFrance1
Tourcoing HospitalTourcoingFrance1
Vestfold Hospital TrustTønsbergNorway2